Federal Register - July 2, 2021
Version en texte Qu'est-ce que c'est?Dateas est un site Web indépendant, non affilié à un organisme gouvernemental. La source des documents PDF que nous publions est l'agence officielle indiquée dans chacun d'eux. Les versions en texte sont des transcriptions non officielles que nous faisons pour fournir de meilleurs outils d'accès et de recherche d'informations, mais peuvent contenir des erreurs ou peuvent ne pas être complètes.
Source: Federal Register
35300
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices To obtain copies of a supporting statement and any related forms for the proposed collections summarized in this notice, you may make your request using one of following:
1. Access CMS website address at website address at https www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid Services Document Identifier: CMS10531
Agency Information Collection Activities: Proposed Collection;
Comment Request Centers for Medicare &
Medicaid Services, Health and Human Services HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services CMS is announcing an opportunity for the public to comment on CMS intention to collect information from the public. Under the Paperwork Reduction Act of 1995 the PRA, federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information including each proposed extension or reinstatement of an existing collection of information and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agencys functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
DATES: Comments must be received by August 31, 2021.
ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to http
www.regulations.gov. Follow the instructions for Comment or Submission or More Search Options to find the information collection documents that are accepting comments.
2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB
Control Number: lll, Room C426
05, 7500 Security Boulevard, Baltimore, Maryland 212441850.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
FOR FURTHER INFORMATION CONTACT:
William N. Parham at 410 7864669.
SUPPLEMENTARY INFORMATION:
Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collections supporting statement and associated materials see ADDRESSES.
CMS10531 Transcatheter Valve Therapy TVT Registry Under the PRA 44 U.S.C. 3501
3520, federal agencies must obtain approval from the Office of Management and Budget OMB for each collection of information they conduct or sponsor.
The term collection of information is defined in 44 U.S.C. 35023 and 5 CFR
1320.3c and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party.
Section 3506c2A of the PRA
requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice.
addressed in this NCD, we replaced the term TMVR with TEER. The TEER
device is only covered when specific conditions are met including that the heart team and hospital are submitting data in a prospective, national, audited registry. The data includes patient, practitioner and facility level variables that predict outcomes such as all-cause mortality and quality of life. In order to remove the data collection requirement under this coverage with evidence development CED NCD or make any other changes to the existing policy, we must formally reopen and reconsider the policy. We are continuing to review and analyze the data collected since the original NCD was effective in 2014 and following the update in 2021.
The data collected and analyzed in the TVT Registry will be used by CMS
to determine if TEER is reasonable and necessary e.g., improves health outcomes for Medicare beneficiaries under Section 1862a1A of the ACT.
Furthermore, data from the Registry will assist the medical device industry and the Food and Drug Administration FDA in surveillance of the quality, safety and efficacy of new medical devices to treat MR. Form Number:
CMS10531 OMB control number:
09381274; Frequency: Annually;
Affected Public: Private sector Business or other for-profits; Number of Respondents: 8,649; Total Annual Responses: 34,596; Total Annual Hours:
12,974. For policy questions regarding this collection contact Sarah Fulton at 4107862749.
Dated: June 28, 2021
William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs.
FR Doc. 202114162 Filed 7121; 8:45 am BILLING CODE 412001P
Information Collection 1. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Transcatheter Valve Therapy TVT Registry; Use: The data collection is required by the Centers for Medicare & Medicaid Services CMS National Coverage Determination NCD entitled, Transcatheter Edge-to-Edge Repair TEER for Mitral Valve Regurgitation and was previously entitled Transcatheter Mitral Valve Repair TMVR. Effective January 19, 2021, CMS updated this NCD to expand coverage to functional mitral regurgitation MR. Previously, coverage was limited to degenerative MR. To more precisely define the treatment
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid Services Document Identifier: CMS10769
Agency Information Collection Activities: Submission for OMB
Review; Comment Request Centers for Medicare &
Medicaid Services, Health and Human Services HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services CMS is announcing an opportunity for the public to comment on CMS intention to collect
SUMMARY:
E:FRFM02JYN1.SGM
02JYN1